Published in
Elsevier, The Annals of Thoracic Surgery, 6(111), p. 2085, 2021
DOI: 10.1016/j.athoracsur.2020.08.090
Links
Tools
Should Neoadjuvant Therapy be a Standard Modality for Patients with Clinical T2N0 Esophageal Cancer?
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 